@article{ajmr2018642,
author={{Bashir, Sanaa and Abd-elrahman, Khoubieb Ali and Hassan, Mohammed A. and Almofti, Yassir A.},
title={Multi Epitope Based Peptide Vaccine against MarekĄ¯s Disease Virus Serotype 1 Glycoprotein H and B},
journal={American Journal of Microbiological Research},
volume={6},
number={4},
pages={124--139},
year={2018},
url={http://pubs.sciepub.com/ajmr/6/4/2},
issn={2328-4137},
abstract={<b>Background</b><b>: </b>MarekĄ¯s disease (MD) is a highly contagious disease of chickens caused by MarekĄ¯s disease virus (MDV). It causes economic losses in poultry industry estimated to be more than 1 billion per year. The aim of this study was to design a peptide vaccine against MarekĄ¯s disease virus serotype 1 (MDV-1) by targeting the Glycoproteins H and B as an immunogens to stimulate protective immune response.<b> </b>A total of 43 Glycoprotein H and 33 glycoprotein B of Gallid alphaherpesvirus 2 (MDV-1) were retrieved from the National Center for Biotechnology Information database (NCBI) in the 13th of October 2017. Several tests at Immune Epitope Database (IEDB) were used to detect the highly conserved immunogenic epitopes that elicit B and T cells and could be used as efficient vaccine candidates. In our results three epitopes from glycoprotein H namely; <SUB>91</SUB><SUB><b>-</b></SUB><b>FYKRPVSKLL</b><SUB><b>-</b></SUB><SUB>100</SUB>, <SUB>255-</SUB><b>LKPYEPVDKF</b><SUB><b>-</b></SUB><SUB>264</SUB>, and <SUB>684-</SUB><b>PRPL</b><SUB><b>-</b></SUB><SUB>687</SUB> and three epitopes of glycoprotein B; <SUB>162-</SUB> <b>EKQV</b><SUB>-165</SUB>, <SUB>234-</SUB><b>YGLSPPE</b><SUB><b>-</b></SUB><SUB>240</SUB>, and <SUB>363-</SUB><b>YNDSHVK</b><SUB>-369</SUB> were fulfilled the criteria of surface accessibility, antigenicity for becoming the most probable B cell epitope. While Four epitopes of glycoprotein H; <SUB>425-</SUB><b>YVLRSAYAF</b><SUB><b>-</b></SUB><SUB>433</SUB>, <SUB>175-</SUB><b>LTSELTGTY-</b><SUB>183</SUB>, <SUB>476</SUB><SUB><b>-</b></SUB><b>LYYAFASIF</b><SUB><b>-</b></SUB><SUB>484</SUB>, and <SUB>367</SUB><SUB><b>-</b></SUB><b>MITETLSTF</b><SUB><b>-</b></SUB><SUB>375</SUB> were addressed as potentially promising epitopes as they bound the highest number of both MHC-I and MHC-II alleles<b> </b>with a high binding affinity to chickens MHC-I molecule (BF2*2101) haplotype in the structural level. Also two epitopes of glycoprotein B; <SUB>598-</SUB><b>FLFGSGYAL</b><SUB><b>-</b></SUB><SUB>606</SUB>, <SUB>727-</SUB><b>FMSNPFGAL</b><SUB><b>-</b></SUB><SUB>735</SUB> were bound with the highest number of both MHC-I and MHC-II with high binding affinity. Taken together<b> </b>MarekĄ¯s disease is a significant disease of poultry. We addressed epitopes from glycoprotein H and B that could act as candidatesĄ¯ vaccine. To our knowledge there is no <i>in silico</i> epitope based vaccine for MarekĄ¯s disease virus serotype 1 (MDV-1). An in vitro and in vivo application is required to prove the efficacy of the predicted epitopes as peptide vaccine.},
doi={10.12691/ajmr-6-4-2}
publisher={Science and Education Publishing}
}
